Brain Atrophy, N-Terminal Brain Natriuretic Peptide, and Carotid Disease
Author(s) -
Sarah T. Pendlebury,
Peter M. Rothwell
Publication year - 2016
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.116.308362
Subject(s) - atrophy , brain natriuretic peptide , medicine , cardiology , endocrinology , heart failure
In this issue, Sabayan et al discuss their findings from the AGES-Reykjavik study, on the association between brain atrophy and baseline N-terminal brain natriuretic peptide (NT-proBNP), a marker of cardiac dysfunction and carotid intima media thickness (CIMT), a marker of carotid atherosclerosis burden.1 They found that both higher NT-proBNP and CIMT were associated with longer term decline in total brain and grey matter volume but not with white matter volume. The highest rates of brain volume decline (at around three times that seen in normal ageing) were seen in subjects with both high NT-proBNP and CIMT and this was independent of age, education and cardiovascular factors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom